Streetbeat News

Earnings

TTWO

Take-Two Interactive (NASDAQ:TTWO) has received 11 analyst ratings in the past three months, with a shift towards more bullish perspectives. The average 12-month price target has increased by 8.8% to $172.09, with a range from $155.00 to $200.00. Analysts from firms like BMO Capital, Wolfe Research, and Deutsche Bank have provided various ratings and price target adjustments, reflecting changes in market conditions and company performance. Take-Two, known for franchises like 'Grand Theft Auto', faces challenges with a revenue decline of -6.77% and a net margin of -41.84%, but has a strong ROE of -6.26% and ROA of -3.54%, with a low debt-to-equity ratio of 0.42.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 2:00 pm

RELL

Richardson Electronics (NASDAQ:RELL) is expected to report Q4 earnings with an EPS of $0.01 on January 10, 2024. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, RELL's stock price has dropped following earnings beats, with a 6.0% decline after last quarter's results. Over the past year, RELL shares have decreased by 42.32%, indicating potential concern for long-term shareholders ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 2:00 pm

TRIP

Analyst ratings for TripAdvisor (NASDAQ:TRIP) show mixed sentiments with an average 12-month price target of $22.5, up from $19.67. Ratings range from 'Buy' to 'Underweight', reflecting diverse opinions on the company's performance. TripAdvisor's financials indicate strong growth and profitability, with a revenue increase of 16.12% and a net margin of 5.07%. The company's market capitalization is below industry benchmarks, but it has a healthy debt-to-equity ratio of 1.11.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 2:00 pm

KBH

KB Home (NYSE:KBH) is expected to release its quarterly earnings report on January 10, 2024. Analysts predict an EPS of $1.70. Investors are looking for an earnings beat and positive guidance for future growth. KB Home's stock performance has been strong, with shares up 74.62% over the last 52 weeks, trading at $62.76 as of January 05. Historical data shows mixed stock price reactions to past earnings performances.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 2:00 pm

TLRY

Tilray Brands, Inc. reported a 34% YoY revenue increase in Q2 fiscal 2024, reaching $194 million. The growth was driven by a 35% increase in cannabis net revenue, a 117% increase in beverage alcohol net revenue, and a rise in distribution net revenue. Gross profit rose 11% to $47 million, and adjusted EBITDA was positive at $10.1 million. The company reduced its net loss and continued to expand its business, including medical cannabis in Europe and the craft beverage-alcohol market in the U.S. Shares of Tilray traded 5.56% higher at $2.47 in pre-market.

Portfolio Pulse from Jelena Martinovic

January 09, 2024 | 1:54 pm

BAC

C

JPM

KBE

SPY

WFC

Top U.S. banks JPMorgan, Citigroup, Bank of America, and Wells Fargo are set to report Q4 earnings on Friday with mixed expectations. Deloitte's 2024 outlook suggests a challenging year for financial services due to economic slowdown, rate cuts, geopolitical tensions, and assertive regulations. Disruptive technologies and other factors like GenAI and digitization will also impact the industry. Last year, KBE gained 3.2%, while SPY gained 16%. Zacks estimates vary for each bank, with JPM expected to post higher earnings and revenue, C to see a decline in earnings but increased revenue, BAC to have lower earnings and revenue, and WFC to report significant earnings growth with slightly higher revenue. Fitch Ratings maintains a deteriorating outlook for banks in 2024, while S&P Global sees steady outlook based on solid fundamentals, and Moody's holds a negative view due to a sluggish growth environment.

Portfolio Pulse from Neil Dennis

January 09, 2024 | 1:54 pm

AYI

XLI

Acuity Brands, Inc (NYSE:AYI) reported a slight miss in Q1 FY24 net sales at $934.7 million versus the consensus of $935.1 million but exceeded EPS expectations with $3.72 against a consensus of $3.23. The company saw a year-over-year sales decline of 9%, with mixed performance across segments. ABL's revenue decreased by 7.5% while ISG's revenue increased by 13.0%. Adjusted operating margins improved, and the company generated higher operating cash flow and adjusted EBITDA compared to the previous year. Acuity Brands' stock reached a 52-week high, outperforming the industrial sector index SPDR Select Sector Fund - Industrial (NYSE:XLI).

Portfolio Pulse from Anusuya Lahiri

January 09, 2024 | 1:54 pm

AYI

Acuity Brands' stock is trading higher following the announcement of their Q1 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:53 pm

NEOG

Neogen Corporation's stock is trading lower following the announcement of disappointing Q2 financial results and a reduction in its sales guidance for FY24, which fell below analyst expectations.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:52 pm

EWTX

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) presented at the 42nd Annual J.P. Morgan Healthcare Conference, highlighting its 2023 accomplishments and 2024 milestones. In 2023, EWTX made significant progress in clinical trials for muscle diseases, including positive trial data for Becker muscular dystrophy and Duchenne muscular dystrophy treatments. The FDA granted Orphan Drug and Rare Pediatric Disease Designations for their drug EDG-5506. For 2024, EWTX plans to report further trial data and initiate a Phase 3 trial for EDG-5506, as well as announce Phase 1 data for their cardiac program EDG-7500.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:49 pm